APP and amyloidosis: APP/PS1 mice were structured based on Aβ pathology, learning-memory deficits accompanied by detectable cerebral Aβ at 4 months, significant amyloidosis at 6–7 months, and further aggravates pathology at 10 months (Blanchard et al., 2003; Jankowsky et al., 2004).